ArticleLuminescence : the journal of biological and chemical luminescence2025
NIR-Excited Imaging of Cervical Cancer Cells Using Biocompatible LaF
Article in Luminescence : the journal of biological and chemical luminescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Rare-Earth Nanomaterials for Advanced Theranostics of Atherosclerosis.Chemical & biomedical imaging · 2026Review
- Recent advances in enhancing the luminescence efficiency of rare earth upconversion nanoparticles for biomedical applications.RSC advances · 2026Review
- NIR-Excited Imaging of Cervical Cancer Cells Using Biocompatible LaFLuminescence : the journal of biological and chemical luminescence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioimaging plays a vital role in understanding complex biological processes, from tracking cellular activity to studying entire organisms. To improve the sensitivity and specificity of imaging techniques, researchers are increasingly turning to nanomaterials as contrast agents. Among them, upconversion nanoparticles (UCNPs) stand out for their ability to convert near-infrared (NIR) light into visible emission. This property enables deep tissue penetration, reduced autofluorescence, and low phototoxicity. We report the synthesis of LaF
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.